HRT Financial’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

HRT Financial’s Portfolio SCPS Stock Details SCPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,353	Closed	-$3K	–	3666
2022 Q3	$3K	Sell	14,353 -43,809	-75%	-$15.9K	﹤0.01%	2643
2022 Q2	$25K	Buy	+58,162	New	+$27.9K	﹤0.01%	2582

Other funds holding SCPS

MRCM

M&R Capital Management Summit, New Jersey $454M AUM 40.11% 1-Year Est. Return

HRT Financial's SCPS Position: Q4 2022 in Review

HRT Financial sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q4 2022, closing a stake of 14,353 shares — an estimated $3K sold.

HRT Financial first reported a position in SCPS in Q2 2022 and held it in 2 quarters. The position peaked at $25K in Q2 2022. 1 fund tracked by Wall St. Rank holds SCPS as of Q4 2022.

HRT Financial reported no remaining Scopus BioPharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
HRT Financial sold 14,353 Scopus BioPharma Inc. Common Stock shares in Q4 2022, an estimated $3K.
HRT Financial first reported a position in Scopus BioPharma Inc. Common Stock in Q2 2022 and held it in 2 quarters.
HRT Financial's Scopus BioPharma Inc. Common Stock position peaked at $25K in Q2 2022.
1 fund tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.